Literature DB >> 9028821

Alpha-, beta-, and gamma-mRNA levels in beta-thalassemia; transcriptional and translational differences in heterozygotes, homozygotes, and compound heterozygotes.

N S Smetanina1, L H Gu, L Simjanovska, A Momirovska, G H Petkov, A D Adekile, G D Efremov, T H Huisman.   

Abstract

We have determined the relative levels of alpha-, beta-, and gamma- (G gamma- and A gamma-) mRNAs in the reticulocytes of patients with mild beta-thalassemia intermedia due to combinations of promoter mutations and a classical type of beta-thalassemia, as well as in their relatives. The expected differences in the alpha/beta-mRNA ratio confirmed the mild suppression of beta-mRNA synthesis, particularly in heterozygotes for the -101 (C-->T) promoter mutation and the large increase in the relative gamma-mRNA level in compound heterozygotes. A significant discrepancy between Hb F and gamma-mRNA levels, observed in previously published studies, was confirmed indicating a less efficient gamma-mRNA translation. When the two different gamma-mRNA (G gamma- and A gamma-) levels were determined it was observed that in beta-thalassemia heterozygotes the extra gamma-mRNA was primarily of the G gamma type suggesting a more efficient translation of the A gamma-mRNA. This difference disappeared in homozygotes and compound heterozygotes: both mRNAs (G gamma- and A gamma-) translate with an equal efficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028821     DOI: 10.3109/03630269708997508

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  1 in total

1.  MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis.

Authors:  Imane Azzouzi; Hansjoerg Moest; Jeannine Winkler; Jean-Claude Fauchère; André P Gerber; Bernd Wollscheid; Markus Stoffel; Markus Schmugge; Oliver Speer
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.